News Image

Why the growth investor may take a look at PROGYNY INC (NASDAQ:PGNY).

By Mill Chart

Last update: Nov 13, 2023

In this article we will dive into PROGYNY INC (NASDAQ:PGNY) as a possible candidate for growth investing. Investors should always do their own research, but we noticed PROGYNY INC showing up in our Louis Navellier growth screen, which makes it worth to investigate a bit more.

Looking into the growth metrics of PROGYNY INC

  • PROGYNY INC exhibits a strong Return on Equity (ROE) of 10.08%, indicating the company's ability to generate solid returns on shareholder investments. This metric reflects the company's efficient utilization of equity capital and its profitability.
  • With a track record of beating EPS estimates in the last 4 quarters, PROGYNY INC showcases its consistent ability to deliver earnings surprises. This reflects the company's strong execution and its competitive position in the market.
  • With impressive 1-year revenue growth of 47.54%, PROGYNY INC showcases its ability to generate increased sales and revenue. This growth highlights the company's strong customer demand and its effective business strategies.
  • The quarter-to-quarter (Q2Q) revenue growth of 36.77% of PROGYNY INC has been strong, reflecting the company's ability to generate consistent sales growth. This growth suggests the company's ability to meet customer needs and drive revenue growth.
  • PROGYNY INC has shown positive growth in its operating margin over the past year, indicating improved operational efficiency. This growth highlights the company's ability to effectively manage costs and maximize profitability.
  • PROGYNY INC has shown positive growth in its free cash flow (FCF) over the past year, indicating improved cash generation and financial strength. This growth highlights the company's ability to effectively manage its cash flows and generate surplus funds.
  • The quarterly earnings of PROGYNY INC have shown a 23.08% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
  • The average next Quarter EPS Estimate by analysts was adjusted by 23.81%, reflecting the evolving market expectations for the company's EPS growth.
  • The quarterly earnings of PROGYNY INC have shown a 23.08% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
  • accelerating EPS growth for PROGYNY INC: the current Q2Q growth of 23.08% exceeds the previous year Q2Q growth of -23.53%.

Fundamental Analysis Observations

ChartMill assigns a proprietary Fundamental Rating to each stock. The score is computed daily by evaluating various fundamental indicators and properties. The score ranges from 0 to 10.

We assign a fundamental rating of 6 out of 10 to PGNY. PGNY was compared to 115 industry peers in the Health Care Providers & Services industry. PGNY is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PGNY is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make PGNY suitable for growth investing!

Check the latest full fundamental report of PGNY for a complete fundamental analysis.

Our Lois Navellier screen will find you more ideas suited for growth investing.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

PROGYNY INC

NASDAQ:PGNY (4/18/2024, 7:13:59 PM)

Premarket: 31.77 -0.11 (-0.35%)

31.88

-0.87 (-2.66%)

PGNY News

News Image15 days ago - ProgynyProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges

News Image15 days ago - ProgynyProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of...

News Imagea month ago - ProgynyProgyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Imagea month ago - InvestorPlaceThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

News Imagea month ago - BusinessInsiderThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Wagering on mid-cap stocks can potentially unlock investment treasures typicall...

News Imagea month ago - ProgynyProgyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Image2 months ago - Seeking AlphaProgyny announces $100M share repurchase program (NASDAQ:PGNY)

Progyny (PGNY) approves $100 million share repurchase program funded by available cash balances.

News Image2 months ago - ProgynyProgyny, Inc. Announces Share Repurchase Program
News Image2 months ago - ProgynyProgyny, Inc. Announces Share Repurchase Program

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Image2 months ago - Market News VideoWednesday Sector Laggards: Hospital & Medical Practitioners, Oil & Gas Refining & Marketing Stocks
News Image2 months ago - ProgynyProgyny, Inc. Announces Fourth Quarter 2023 Results
News Image2 months ago - ProgynyProgyny, Inc. Announces Fourth Quarter 2023 Results

Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint

PGNY Links
Follow us for more